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INTRODUCTION 
 
Activated microglia play key roles in neuro-
inflammation and depending on the nature of the initial 
stimulus their actions may be either beneficial or 
detrimental to neuronal function. In the latter case, 
activated microglia undergo phenotypic polarization 
toward a so called M1 pro-inflammatory phenotype and 
produce neurotoxic factors, such as inflammatory 
cytokines, reactive oxygen species, nitric oxide synthase 
(NOS), and glutamate [1, 2]. In contrast, activated 
microglia can be polarized into an anti-inflammatory 
phenotype  defined  as  M2  phenotype  expressing  anti- 
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inflammatory cytokines, growth factors, and unique 
membrane receptors [3, 4].  
 
Chronic neuroinflammation involves the sustained 
activation of microglia, and consequent release of 
proinflammatory mediators, which are detrimental for 
the neuronal cell population.  In chronic neuro-
degenerative diseases, microglia remain activated for an 
extended period during which the production of 
mediators is sustained longer than usual, thus 
contributing to neuronal death. Compelling evidence 
suggests that inflammation plays an important role in 
the cell loss observed in Parkinsons disease (PD) [5-7]. 
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Abstract: Increasing evidence involves sustained pro inflammatory microglia activation in the pathogenesis of different
neurodegenerative diseases, particularly Parkinsons disease (PD). We recently uncovered a completely novel and
unexpected role for caspase 8 and its downstream substrates caspase 3/7 in the control of microglia activation and
associated neurotoxicity to dopaminergic cells. To demonstrate the genetic evidence, mice bearing a floxed allele of CASP8
were crossed onto a transgenic line expressing Cre under the control of Lysozyme 2 gene. Analysis of caspase 8 gene
deletion in brain microglia demonstrated a high efficiency in activated but not in resident microglia. Mice were challenged
with lipopolysaccharide, a potent inducer of microglia activation, or with MPTP, which promotes specific dopaminergic cell
damage and consequent reactive microgliosis. In neither of these models, CASP8 deletion appeared to affect the overall
number of microglia expressing the pan specific microglia marker, Iba1. In contrast, CD16/CD32 expression, a microglial
pro inflammatory marker, was found to be negatively affected upon CASP8 deletion. Expression of additional
proinflammatory markers were also found to be reduced in response to lipopolysaccharide. Of importance, reduced pro
inflammatory microglia activation was accompanied by a significant protection of the nigro striatal dopaminergic system
in the MPTP mouse model of PD.
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Epidemiological studies have demonstrated that 
incidence of idiopathic PD is about 50% lower in 
chronic users of non-steroidal anti-inflammatory drugs 
or cyclo-oxygenase inhibitors than in age-matched non-
users [8, 9]. Inflammation has been shown in different 
animal models of PD. Among them, the acute 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model has 
been demonstrated to encompass a significant 
inflammatory response in the SN pars compacta 
(SNPC) along with degeneration of the nigro-striatal 
dopaminergic system [10-12]. LPS is the active 
immunostimulant in the cell wall of Gram-negative 
bacteria that is responsible for triggering the cascade of 
events following bacterial infection [13, 14]. 
Interestingly, the SN is especially susceptible to the 
LPS-induced neurotoxicity as compared with other 
brain areas [15]. In this structure, the strong microglial 
response to LPS preceded the death of dopaminergic 
neurons [16, 17].  
 
Caspases, a family of cysteinyl aspartate-specific 
proteases, are best known as executioners of apoptotic 
cell death and their activation are considered as a 
commitment to cell death ([18]. However, certain 
caspases also function as regulatory molecules for 
immunity, cell differentiation and cell-fate 
determination [19]. 
 
We have described an unexpected novel function for 
caspases in the control of microglia proinflammatory 
activation and thereby neurotoxicity [20]. We showed 
that the orderly activation of caspase-8 and caspase-3/7, 
known executioners of apoptotic cell death, regulates 
microglia activation. We found that stimulation of 
microglia with various inflammogens activates caspase-
8 and caspase-3/7 in absence of cell death in vitro and 
in vivo. Importantly, we also observed that these 
caspases are activated in microglia in the substantia 
nigra in PD subjects [20]. 
 
We aim at providing the genetic evidence that targeting 
CASP8 gene selectively in the microglia cell population 
in the brain can provide neuronal beneficial effect in 
animal models of PD. We have taken advantage of 
conditional knock-out genetic approaches in the 
myeloid system, including microglia in the brain, to 
examine cell-specific effects of caspase-8 signaling in 
the intranigral LPS model and the acute MPTP model of 
Parkinson's disease, well-established paradigms of 
dopaminergic neurodegeneration that induces a robust 
inflammatory response in the substantia nigra. In these 
models, we confirmed in vivo the importance of 
caspase-8 in regulating the proinflammatory response of 
activated microglia. 
RESULTS 
 
Generation of conditional caspase-8 knockout mice 
in myeloid cells and evaluation of caspase-8 gene 
deletion in resident and activated microglia 
 
Caspase-8 floxed animals (Casp8fl/fl) expressing 
Lysoxyme 2 (LysM) Cre will be referred to as 
CreLysMCasp8fl/fl. Analysis of caspase-8 staining in the 
substantia nigra after LPS intranigral injection 
revealed a significant decrease in cleaved caspase-8 in 
CreLysMCasp8fl/fl mice (Fig. 1d,e). We performed dual 
caspase-8 and Iba1 immunofluorescence after either 
intranigral LPS injection or MPTP administration. 
Cleaved caspase-8 immuofluorescence was detected in 
Iba1-positive cells of Casp8fl/fl mice after stimulation 
with either LPS or MPTP. Reduced cleaved caspase-8 
staining was observed in Iba1-positive cells of 
CreLysMCasp8fl/fl mice, confirming the depletion of 
caspase-8 in brain myeloid cells (Fig. 1e). Some 
concerns have been recently raised concerning the use 
of CreLysM mice to specifically target adult microglia 
[21]. Previous studies reported a high rate of 
recombination in brain microglia when using these 
mice [22, 23]. In contrast, an average recombination 
rate of about 45% was obtained in Iba1-labelled 
resident microglia from CreLysM mice. However, our 
immunohistochemical analysis demonstrated an almost 
absence of cleaved caspase-8 immunoreactivity in 
reactive microglia, suggesting an effective deletion of 
Caspase-8 gene in those cells in the CreLysM mice. 
Ascertaining the rate of Caspase-8 gene deletion in 
our experimental conditions is of critical importance 
considering the modest degree of recombination 
reported by Goldmann et al [21]using CreLysM mice. 
We wondered whether resting and activated microglia 
could exhibit different rates of gene deletion in the 
CreLysM mice. To achieve that, we isolated microglia 
from the ventral mesencephalon from intact and LPS-
injected mice. Microglia were immunopurified using 
CD-11b-labelled microbeads after myelin removal by 
Percoll treatment. The purity of the microglia 
preparation was evaluated by flow cytometry analysis 
using CD-11b and CD-45 antibodies (Fig. 1b). 
Genomic DNA was isolated from resting and activated 
microglia and deletion of the Caspase-8 floxed 
sequence was evaluated following an ABC primer 
strategy. While primers A and B detect the floxed 
sequence, primers A and C do not amplify unless the 
floxed sequence is deleted (Fig. 1a). We have 
recently developed mice in which one of the caspase-
8 alleles was knocked out (50% deletion). Microglia 
isolated from these mice was used to normalize the 
QPCR analysis. By using this approach, resident 
microglia  from  CreLysMCasp8fl/fl   mice  rendered   an 
www.impactaging.com 674 AGING, September2015, Vol. 7 No.9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Generation of CreLysMCasp8fl/fl mice and validation of Caspase 8 deletion. Panel (a) contains a schematic
illustration of the mouse genomic locus showing the insertion of the targeted allele flanked with LoxP sites (upper), and the
deleted allele after Cre recombination (lower). Locations of primers A, B and C used for the PCR deletion study are also shown.
Flow cytometry demonstrating the purity of the microglial fraction (b) used to assess the degree of caspase 8 gene deletion (c)
based on an ABC primer strategy. The degree of gene caspase 8 gene deletion was evaluated in mesencephalic resident and
activated microglia. QPCR demonstrated a low caspase 8 gene deletion in resident microglia and a dramatic increase in activated
microglia. mRNA analysis of Lysozyme 2 and caspase 8 in microglia isolated from the ventral mesencephalon from
CreLysMCasp8fl/fl mice corroborated the striking differences between resident and activated microglia (c). Panel (d) shows
immunohistochemistry of cleaved caspase 8 in the ventral mesencephalon of Casp8
fl/fl
and CreLysMCasp8fl/fl mice after intranigral
LPS injection. Panel (e) shows immunofluorescence of cleaved caspase 8 and Iba1 showing co staining in MPTP injected Casp8
fl/fl
mice, and absence of cleaved caspase 8 staining in CreLysMCasp8fl/fl mice (f). Scale bar: e: 300 µm; f: 20 µm.
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extremely low level of Caspase-8 gene deletion (7.1 ± 
3.2%), a level even lower than that reported by 
Goldmann et al [21]. In contrast, activated microglia 
obtained from the ventral mesencephalon from LPS-
injected animals showed a very high rate of Caspase-8 
gene deletion (75.4 ± 10.2) (Figure 1). A similar 
approach has been previously employed by Cho and 
coworker [24]. Indeed, the authors stimulated 
CreLysMIKK f/f mice in vivo by i.c.v LPS injection and 
kainic acid injection, and demonstrated that the deletion 
rate is notably increased upon microglia activation. 
Furthermore, the authors demonstrated significantly less 
proinflammatory microglia activation in the mice 
subjected to kainic acid treatment [24]. To further 
validate the efficiency of Caspase-8 gene deletion, we 
analyzed the mRNA levels of Lysozyme M and caspase-
8 from microglia isolated from the ventral 
mesencephalon 24h after intranigral LPS injections. As 
seen in Fig. 1c, Lysozyme M mRNA levels were robustly 
up-regulated in activated microglia. Under these 
conditions, caspase-8 mRNA levels dropped to 30% of 
levels of resident microglia obtained from C 
CreLysMCasp8fl/fl reLysMCasp8fl/fl CreLysMCasp8fl/fl mice. 
Due to tissue dissecting limitations, it is reasonable to 
assume that not all microglia isolated from the ventral 
mesencephalon from LPS-injected animals are activated. 
Consequently, we may conclude that CreLysMmice are 
valid to target adult microglia under experimental 
conditions leading to proinflammatory activation.  
 
 
Caspase-8 deletion in myeloid cells blocks microglia 
activation in LPS neuroinflammatory model 
 
As a first approach, we used intranigral injections of 
LPS, a major endotoxin acting as a ligand of TLR4 and 
known to induce a classically proinflammatory 
activation of microglia. Intranigral injection of LPS has 
been shown to induce an extensive activation of 
microglia along with degeneration of substantia nigra 
dopaminergic neurons [16, 25].  
 
Immunohistochemistry analysis of microglia/macro-
phage population 
Tissues were immunostained with Iba1, a pan specific 
marker of microglia/macrophages and CD16/32, a 
specific marker for the proinflammatory phenotype. We 
analyzed the effect of two in vivo doses of LPS, 2 and 4 
µgs. Caspase-8 inhibition in LPS-induced activated 
microglia has been shown to induce necroptosis [26, 
27], a RIPK1/RIPK3-dependent process [28, 29]. 
Analysis of microglia using Iba1 did not show 
differences in Cre CreLysMCasp8fl/fl LysMCasp8fl/fl mice 
as compared with Casp8fl/fl mice in response to LPS 
(Fig. 2a, b), an indication that necroptosis was not 
occurring in our experimental conditions. Upon LPS 
treatment, there was a marked microglia morphological 
change as characterized by Iba1 reactivity; further 
thickening of processes, retraction of finer ones, 
increased cell body size and Iba1 reactivity (Fig. 2a, d). 
In addition, numerous amoeboid-shaped cells could be 
observed in LPS-injected animals in both Casp8fl/fl mice 
and CreLysMCasp8fl/fl mice. Since Iba1 does not clearly 
discern between resident and activated microglia, we 
used a specific marker for the proinflammatory 
phenotype of microglia, CD16/32 [30-32]. CD16/32 
was significantly up-regulated in Iba-1-labeled 
microglia from Casp8fl/fl mice (Fig. 2d). However, this 
LPS-induced up-regulation of microglial CD16/32 was 
significantly attenuated in CreLysMCasp8fl/fl mice (Figs. 
2a, b, d and 3a). Dual immunofluorescence of Iba1 and 
CD16/32 demonstrated that upon saline injection there 
was some degree of microglia activation characterized 
by increased ramification of cytoplasmic process and 
cell size and enhanced Iba1 labeling (Fig. 2d). Under 
these conditions, most if not all CD16/32 positive cells 
were also positive for Iba1 (Fig. 2d).  
 
Analysis of cleaved caspase-8 in proinflammatory 
microglia after LPS 
We then analyzed the extent of active cleaved caspase-8 
in activated microglia in the ventral mesencephalon in 
response to LPS injection. We found a widespread 
distribution of cleaved caspase-8 cells in LPS-injected 
Casp8fl/fl mice (Fig. 3a, b). In CreLysMCasp8fl/fl mice, the 
labeling of cleaved caspase-8 was extremely low (Fig. 
3a). Considering that we used conditional CASP8 knock 
out mice, our data suggest that under conditions of 
proinflammatory microglia activation, there is a 
selective activation of caspase-8 within 
microglia/macrophages. This observation is in line with 
our previous data demonstrating selective activation of 
caspase-8 in reactive microglia in the ventral 
mesencephalon from PD patients [20]. To demonstrate 
this, we performed double cleaved caspase-8 and 
CD16/32 immunofluorescence. The analysis 
demonstrated that most cleaved caspase-8 labeling in 
LPS-injected Casp8fl/fl mice was restricted to CD16/32-
labeled microglia (Fig. 3a, b). 
 
QPCR analysis of proinflammatory mediators 
Previous short-term temporal analysis revealed that the 
highest induction of cytokines occurred 6h after the 
LPS-injection, with a decrease at 48 h [25]. 
Consequently, we analysed key proinflammatory 
cytokines including interleukin (IL) IL-1 , IL-6 and 
tumor necrosis factor-  (TNF- ) along with iNOS in the 
ventral mesencephalon from either Casp8fl/fl mice or 
CreLys CreLysMCasp8fl/fl MCasp8fl/fl mice 6h after 
injection of 2 µg LPS. As expected, LPS injection 
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induced significant up-regulation of all proinflammatory 
markers in Casp8fl/fl mice animals in response to LPS 
(Fig. 3c). Strikingly, CreLysM Casp8fl/fl mice significantly 
prevented LPS-induced up-regulation of all pro-
inflammatory markers analysed (Fig. 3c). Of note, iNOS 
levels   in  response  to  LPS,   a   prototypic  M1  marker, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ranged from 4.5-fold in Casp8fl/fl mice to 1.25-fold in Cr 
CreLysMCasp8fl/fl eLysMCasp8fl/fl mice (as compared with 
saline levels from Casp8fl/fl mice) (Fig. 3c). IL-1  levels 
in response to LPS ranged from near 3-fold in Casp8fl/fl 
mice to 0.8-fold in CreLysMCasp8fl/fl mice (as compared 
with saline levels of Casp8fl/fl mice) (Fig. 3c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Microglial caspase 8 deficiency ameliorates proinflammatory microglia activation in the substantia nigra in
response to intranigral LPS injection. Panel (a) shows an illustration of Iba1 and CD16/32 labeled microglia in the ventral
mesencephalon in response to either saline or intranigral LPS in Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice. The effect of LPS and
caspase 8 deficiency on the number of total microglia (Iba1) or proinflammatory microglia (CD16/32) in the substantia nigra is shown
in panels (b) and (c). Results are the mean ± SD of a minimum of four independent experiments and are expressed as number of cells
per mm
2
. Statistical significance was calculated by analysis of variance followed by the least significant difference post hoc test for
multiple range comparisons (p<0.05). Panel (d) shows an illustration of dual immunofluorescence of Iba1 and CD16/32 labeled
microglia in the ventral mesencephalon in response to saline or intranigral LPS in Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice. Merge
photographs shown in (d) are higher magnification photographs of dot boxes depicted in the left column. Note the completely
different morphological features of microglia in response to saline or LPS (d). No apparent differences in terms of Iba1 were detected
between Casp8fl/fl mice and CreLysMCasp8fl/fl mice (a, b, d). Also note the specific labeling of CD16/32, a proinflammatory marker of
microglia activation, which is located in the membrane of microglia (d). Also note how the expression of CD16/32 is clearly down
regulated in response to caspase 8 deficiency (a, c, d). Scale bar: a, 100 µm; d: Iba1 and CD16/32 staining: 50 µm; merge: 20 µm.
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Caspase-8 deletion in myeloid cells blocks microglia 
activation in MPTP Parkinsons disease model 
 
We have previously demonstrated i) a significant 
disruption of the blood brain barrier in response to 
intranigral LPS injections , ii) a significant peripheral 
infiltration in nigral tissue [33], a view supported in 
double transgenic mouse expressing GFP-tagged 
microglia and RFP-tagged monocytes (unpublished 
observations).   Consequently,   we  decided  to  use  the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MPTP model, which is associated to a minimal blood 
brain barrier disruption, thus mimicking vascular 
conditions in PD [34, 35]. The MPTP acute mouse 
model trigger degeneration of nigro-striatral 
dopaminergic neurons along with significant brain 
inflammatory response [36, 37]. Besides, it has been 
demonstrated that resident microglia predominate over 
infiltrating myeloid cells in the MPTP mouse model of 
PD [38] thus making this model very suitable when 
studying the role of caspase-8 in microglia activation. 
Figure 3. Caspase 8 is activated in viable CD16/32 immunolabeled microglia in substantia nigra in response to
intranigral LPS injection, which is associated to higher key proinflammatory microglial markers. Panel (a) shows an
illustration of dual immunofluorescence of cleaved caspase 8 and CD16/32 in substantia nigra in response to intranigral LPS in
Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice. Note how cleaved caspase 8 labeling is mostly associated to CD16/32 labeled
microglia, which is dramatically decreased in CreLysMCasp8fl/fl mice. Panel (b) shows higher magnification photograph of that
shown in panel (a) demonstrating active caspase 8 within viable CD16/32 immunolabeled microglia in Casp8
fl/fl
mice after LPS.
Panel (c) shows the effect of LPS on mRNA expression of inducible nitric oxide synthase (iNOS), tumour necrosis factor (TNF
), interleukin 6 (IL 6) and interleukin 1 in substantia nigra of Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice. mRNA levels were
measured by quantitative PCR. Results are mean ± SD of at least four independent experiments and are expressed as relative
quantification (RQ), calculated using the delta Ct method. Statistical significance was calculated by one way analysis of variance
followed by the least significant difference post hoc test for multiple range (p<0.05). As expected, LPS injection increased the
expression levels of mRNA in Casp8fl/fl mice (WT). This induction was highly prevented in CreLysMCasp8fl/fl mice (KO). Note the
extremely low levels of IL 1 in CreLysMCasp8fl/fl mice. Scale bar: a: 30 µm; b: 10 µm.
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Figure 4. Microglial caspase 8 deficiency ameliorates proinflammatory microglia activation in the
substantia nigra in response to MPTP. Panel (a) shows an illustration of Iba1 and CD16/32 labeled microglia in the
substantia nigra in response to either saline or MPTP in Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice. Injection of saline in
Casp8
fl/fl
mice was not different from CreLysMCasp8fl/fl mice and hence only Casp8
fl/fl
mice saline is shown. Inserts are
high magnification photographs to show more precisely the morphological features of microglia. Panels (b) and (c) show
the stereological analysis of total microglia (Iba1) (b) or proinflammatory microglia (CD16/32) (c) in the substantia nigra of
Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice after MPTP. Results are the mean ± SD of a minimum of four independent
experiments and are expressed as number of cells per mm3. Statistical significance was calculated by analysis of variance
followed by the least significant difference post hoc test for multiple range comparisons (p<0.05). Panel (d) shows
illustration of dual immunofluorescence of Iba1 and CD16/32 labeled microglia in the substantia nigra in response to
saline or MPTP in Casp8fl/fl mice and CreLysMCasp8fl/fl mice. Panel (e) are higher magnification photographs of dot boxes
depicted in Note the drastic changes in the microglia morphology in terms of Iba1 labeling in response to MPTP in both
Casp8fl/fl mice and CreLysMCasp8fl/fl mice (a, d). Also note how CD16/32 immunolabeled proinflammatory microglia is
strongly up regulated in response to MPTP in Casp8fl/fl mice, particularly in the pars compacta of SN (a,d), this effect being
notably hindered inCreLysMCasp8fl/fl mice . Scale bar: a: 350 µm; d: Iba1 and CD16/32 staining: 300 µm; merge: 35 µm.
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Immunohistochemistry analysis of microglia/macro-
phage population in the nigro-striatal system 
 
Under control conditions, typical resting microglia were 
distributed over the ventral mesencephalon in both 
Casp8fl/fl mice and CreLysMCasp8fl/fl mice (Fig. 4a, d). 
Stereological analysis demonstrated no differences 
between the two groups (Fig. 4b). Following acute 
MPTP administration, a significant increase in 
microglia density was detected in  the  ventral  mesence- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
phalon. No significant differences were found in terms 
of microglia density in the two experimental groups 
(Fig. 4a, b). Of note, microglia underwent drastic 
morphological changes especially in the SN pars 
compacta, these changes being more evident in Casp8fl/fl 
mice than in CreLysMCasp8fl/fl mice (Fig. 4a, d). Further, 
most of these microglia located in the SNPC were 
morphologically round (Fig. 4a), thus suggesting a 
phagocytic status, most likely of degenerating 
dopaminergic nigral neurons.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Microglial caspase 8 deficiency ameliorates
MPTP induced proinflammatory microglia activation
in the striatum. Panel (a) shows illustration of Iba1 and
CD16/32 labeled microglia in the striatum in response to
either saline or MPTP in Casp8fl/fl mice and CreLysMCasp8fl/fl
mice. Injection of saline in Casp8fl/fl mice was not different
from CreLysMCasp8fl/fl mice and hence only Casp8fl/fl mice
saline is shown. Panels (b) and (c) show the stereological
analysis of Iba1 (b) and CD16/32 (c) in the striatum in
response to MPTP. Results are the mean ± SD of a minimum
of four independent experiments and are expressed as
number of cells per mm3. Statistical significance was
calculated by analysis of variance followed by the least
significant difference post hoc test for multiple range
comparisons (p<0.05). Panel (d) shows illustration of dual
immunofluorescence of Iba1 and CD16/32 labeled microglia
in the striatum in response to either saline or MPTP in
Casp8fl/fl mice and CreLysMCasp8fl/fl mice. Panel (e) show
higher magnification photographs of dot boxes depicted in
panel (d). Note the drastic changes in the microglia
population in terms of Iba1 labeling in response to MPTP in
both Casp8
fl/fl
mice and CreLysMCasp8fl/fl mice (a,d). Note
the low levels of CD16/32 labeling in the unlesioned striatum
(a, c, d) and how this marker is robustly up regulated in
response to MPTP in Casp8
fl/fl
mice (a, c, d). Also note how
the MPTP induced up regulation of proinflammatory
microglia in tems of CD16/32 is hindered in CreLysMCasp8fl/fl
mice. Scale bar: a: 125 µm; d: Iba1 and CD16/32 staining: 50
µm; merge: 20 µm.
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As a further step, we analysed the phenotype of 
proinflammatory microglia in response to MPTP by 
means of CD16/32 immunohistochemistry. In Casp8fl/fl 
mice there was a remarkable similarity in terms of 
number and morphology between Iba1- and CD16/32-
labelled cells in the ventral mesencephalon from MPTP-
injected animals (Fig. 4a). Again, cells expressing high 
levels of CD16/32 were precisely located in the SNPC 
(Fig. 4a, d). In CreLysMCasp8fl/fl mice, however, analysis 
demonstrated significantly less density of CD16/32-
labeled cells in the ventral mesencephalon in response 
to MPTP, a clear indication of significant less 
proinflammatory microglia activation (Fig. 4c). Double 
Iba1 and CD16/32 immunofluorescence demonstrated 
that all these CD16/32-labelled cells were microglia 
(Fig. 4 d, e).  
 
In the striatum, no significant differences were found in 
terms of density of Iba1-labeled microglia in saline-
injected animals between Casp8fl/fl mice and 
CreLysMCasp8fl/fl mice (Fig. 5a, b, d). Similarly, the 
labelling of CD16/32 in striatum of saline-injected 
animals was very low in both experimental groups in 
accordance with a resting microglial phenotype (Fig. 5a, 
c, d).  In response to MPTP, there were drastic changes in 
the striatal  microglia  population  in  both  Casp8fl/fl  mice  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and CreLysMCasp8fl/fl mice (Fig. 5a, b, d). However, 
when proinflammatory microglia activation was analysed 
in both groups, Casp8fl/fl mice showed significant higher 
density of CD16/32-labeled microglia as compared with 
CreLysMCasp8fl/fl mice (Fig. 5 a, c, d). 
 
Analysis of cleaved caspase-8 in proinflammatory 
microglia after MPTP 
 
We also analysed the extent of activated caspase-8 in 
the ventral mesencephalon 72h after MPTP in both 
Casp8fl/fl mice and CreLysMCasp8fl/fl mice. In Casp8fl/fl 
mice, and found a widespread activation of caspase-8 in 
the ventral mesencephalon, which was highly but not 
totally abrogated in CreLysMCasp8fl/fl mice (Fig. 5d). 
Nevertheless, this observation also points out a precise 
association between caspase-8 activation and 
proinflammatory microglia. Phenotypic characterization 
of cleaved caspase-8 labelled cells demonstrated that 
most of them were also positive for CD16/32 in 
Casp8fl/fl mice. Most cleaved caspase-8 labelling in 
CreLysMCasp8fl/fl mice was localized in non-CD16/32-
labeled cells (Fig. 6). However, a few cells were 
positive for both cleaved caspase-8 and CD16/32, which 
suggests that the rate of CASP8 gene deletion in 
microglia is high but not complete. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Caspase 8 is activated in viable CD16/32 immunolabeled microglia in substantia nigra in response
to intranigral LPS injection, which is associated to higher key proinflammatory microglial markers. Panel (a)
shows illustration of dual immunofluorescence of cleaved caspase 8 and CD16/32 in substantia nigra in response to
intranigral LPS in Casp8fl/fl mice and CreLysMCasp8fl/fl mice. Note how cleaved caspase 8 labeling is mostly but not
completely associated to CD16/32 labeled microglia, which is decreased in CreLysMCasp8fl/fl mice. In both, Casp8fl/fl mice
and CreLysMCasp8fl/fl mice, some non CD16/32 labeled cells express cleaved caspase 8. Arrows indicate viable
proinflammatory CD16/32 labeled microglia expressing active caspase 8 in Casp8fl/fl mice after MPTP. Scale bar: 30 µm.
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Analysis of the nigro-striatal dopaminergic system 
 
We performed a stereological quantification of 
dopaminergic nigral neurons and a densitometric 
analysis of striatal dopaminergic nerve terminals. Acute 
MPTP administration reduced by 45% the total number 
of  tyrosine hydroxylase (TH)-immunopositive neurons 
in the SN of Casp8fl/fl mice. In CreLysMCasp8fl/fl mice, 
the reduction in TH-immunopositivity was 24%, with 
this effect being close to statistical significance (Fig. 7a, 
b).  
 
Analysis of striatal dopaminergic nerve terminal density 
demonstrated a 72% decrease in MPTP-injected 
Casp8fl/fl   mice   in   comparison   with    saline-injected  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
animals (Fig. 7c, d). However, in CreLysMCasp8fl/fl mice, 
the loss was significantly lower (47% as compared with 
saline-injected animals; p<0.05) (Fig. 7c, d). 
 
DISCUSSION 
 
We have previously demonstrated a significant role of 
caspase-8 and caspase-3/7 in the proinflammatory 
activation of microglia [20]. In this study, we have 
taken advantage of conditional caspase-8 KO mice 
specifically in the myeloid system to test the in vivo 
involvement of caspase-8 in microglia activation in 
animal models of Parkinsons disease. A recent study 
by Prinz and colleagues [21] analyzed the rate of 
recombination in resident microglia from 
Figure 7. Caspase 8 deficiency protects the nigro striatal dopaminergic system against the MPTP
induced neurodegenerative changes. Illustration of tyrosine hydroxylase (TH) immunoreactivity in substantia
nigra (a) and striatum (c) in response to either saline or MPTP in Casp8
fl/fl
and CreLysMCasp8fl/fl mice. Stereological
quantification of TH labeled neurons of each condition is shown in (b). There was less loss of nigra dopaminergic
neurons in response to MPTP in CreLysMCasp8fl/fl mice, this effect being close to statistical significance. Analysis of
integrity of striatal dopaminergic nerve endings (d) demonstrated significantly less MPTP induced loss of TH
immunoreactivity in CreLysMCasp8fl/fl mice as compared with Casp8fl/fl mice (p<0.05). Scale bar: a: 400 µm; c: 500 µm.
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CreLysMTAK1fl/fl mice reaching values (about 45%) far 
away from being optimal to undertake conditional gene 
deletions studies. However, a study by Cho et al [24] 
demonstrated that under conditions of microglia 
activation, the degree of gene deletion dramatically 
increases when using CreLysMl mice. We explored the 
possibility whether similar degree of gene deletion 
could be observed in activated microglia in our animal 
model. To achieve this, we isolated microglia from the 
ventral mesencephalon of CreLysMCasp8fl/fl mice. 
Resident microglia were isolated from unlesioned 
animals and proinflamamatory activated microglia from 
intranigrally LPS-injected animals. The degree of 
Caspase-8 gene deletion in resident microglia was very 
low (about 7%), which is significantly less than that 
obtained in other studies using CreLysM mice [21, 24]. 
This observation may suggest a survival role of caspase-
8 in resident microglia. Strikingly, a dramatic increase 
in the rate of Caspase-8 gene deletion was detected in 
proinflammatory activated microglia from the 
mesencephalon (about 75%), in accordance to an up-
regulation of LysM in activated microglia. The QPCR 
analysis of caspase-8 fully supported the gene deletion 
study. Besides, upon intranigral LPS injection, a strong 
microglial up-regulation of cleavage caspase-8 was 
detected in the ventral mesencephalon of Casp8fl/fl mice, 
which was mostly abolished in CreLysMCasp8fl/fl mice. 
Taken together, we conclude that CreLysMCasp8fl/fl mice 
are valid to investigate the in vivo role of caspase-8 in 
proinflammatory microglia activation.  
 
CreLysMCasp8fl/fl mice did not show significant 
differences in terms of density of Iba1-labelled 
microglia in response to either intranigral LPS injection 
or acute MPTP injections. However, analysis of specific 
proinflammatory microglia demonstrated a negative 
correlation between levels of active caspase-8 and 
proinflammatory microglia activation, thus supporting 
the view that caspase-8 plays a significant role in 
inflamed microglia. In addition, the reduction of 
proinflammatory microglia activation seen in the MPTP 
mouse model of PD was accompanied by a significant 
protection of the nigro-striatal dopaminergic system in 
CreLysMCasp8fl/fl mice. 
 
The main goal of this study was to demonstrate the gene 
involvement of caspase-8 in microglia-derived brain 
inflammation under in vivo conditions. CASP8 null 
animals are not viable due to embryonic lethality around 
embryonic day E10.5 [39] indicating a vital role for 
caspase-8 in embryonic development. Ablation of 
RIPK3 completely rescues the lethality of CASP8 
deficient mice [29, 40]. These findings highlighted non-
apoptotic survival roles of caspase-8 [41, 42]. 
Subsequent works demonstrated that caspase-8 
suppresses a RIPK1-RIPK3-dependent programmed 
necrosis, also known as necroptosis [28, 43]. Recently, 
two independent groups demonstrated that inhibition of 
caspase-8 induces necroptosis in inflammatory activated 
primary microglia but not in neurons, astrocytes, or 
unactivated microglia [26, 27]. The question that arises 
from these observations is related to the existence or not 
of in vivo necroptosis of activated microglia under 
conditions of caspase-8 gene deletion. We tested two 
different animal models, intranigral LPS injections and 
the acute MPTP model. The substantia nigra shows a 
high density of resident microglia as compared with 
other brain areas [44] and more importantly, it has been 
demonstrated to be highly sensitive to proinflammatory 
stimuli including LPS [15, 16, 25]. Our analysis of 
microglia population in response to intranigral LPS 
injections using the pan microglia marker Iba1 did not 
detect significant differences in microglial numbers 
between Casp8fl/fl and CreLysMCasp8fl/fl mice. The same 
was seen in the acute MPTP mouse model of PD. A 
robust but transient activation of microglia is observed 
shortly after using this model [10, 11], hence, analysis 
of microglia after MPTP was performed at 3 days 
postinjection. We failed to detect significant differences 
in terms of microglia density between Casp8fl/fl and 
CreLysMCasp8fl/fl mice. It remains to be established if 
complete CASP8 gene deletion is needed to trigger 
necroptosis in activated microglia. It is noteworthy that 
primary rat activated microglia are more prone to 
trigger necroptosis than mouse activated microglia to 
TLR3/4 stimulation and caspase inhibition [27]. 
 
Very interestingly, the group by Guy Brown and 
colleagues besides demonstrating the existence of 
necroptosis in activated microglia in response to 
caspase-8 inhibition in vitro, they demonstrated that 
LPS and other proinflammogens activated caspase-8 in 
microglia without inducing apoptosis [26]. These results 
are in line with our previous observations that that 
activation of microglial cells with different 
proinflammogens led to modest but significant 
activation of caspase-8 activity in absence of significant 
cell death [20]. With these precedents, we analyzed the 
extent of cleaved caspase-8 in the ventral 
mesencephalon in two in vivo models, intranigral LPS 
and MPTP.  Interestingly, significant caspase-8 
cleavage was detected in viable activated microglia in 
the ventral mesencephalon in Casp8fl/fl mice in response 
to either intranigral LPS or MPTP. This caspase-8 
activation was mostly abrogated in CreLysMCasp8fl/fl 
mice, thus highlighting non-apoptotic roles of caspase-8 
in reactive microglia. These observations are in line 
with our previous observations when we analyzed 
postmortem brain tissue from patients who have been 
diagnosed with Parkinsons disease in terms of protein 
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expression of cleaved caspase-8 and the microglia 
marker CD68 and found significant cytoplasmic 
expression of active caspase-8 in the Parkinsons 
disease ventral mesencephalon [20].  
 
We have previously demonstrated that chemical 
inhibition or gene knockdown of caspase-8 led to 
significantly less proinflammatory microglia activation in 
terms of iNOS and proinflammatory cytokine induction 
in response to different proinflammogens [20]. 
Consequently, we performed a QPCR analysis of key 
proinflammatory genes in the ventral mesencephalon in 
response to intranigral LPS in both Casp8fl/fl mice and 
CreLysMCasp8fl/fl mice including iNOS, TNF- , IL-6 and 
IL-1 .  Analysis was performed at 6h after LPS, when 
most relevant changes take place. As expected, in 
Casp8fl/fl mice, LPS highly induced all markers examined 
as compared with saline-injected animals. Notably, all 
proinflammatory markers examined were significantly 
lower in CreLysMCasp8fl/fl mice than in Casp8fl/fl mice. 
Striking differences were found for iNOS and IL-1 . 
First, levels of both markers were constitutively lower in 
saline-injected CreLysMCasp8fl/fl mice than in Casp8fl/fl 
mice. Second, levels of both markers were either not 
different (iNOS) or even lower (IL-1 ) in LPS-injected 
CreLysMCasp8fl/fl mice as compared with saline-injected 
Casp8fl/fl mice. Taken together, these results point to a 
dysregulated proinflamamtory microglia phenotype in 
CreLysMCasp8fl/fl mice.  
 
Recent reports have demonstrated a novel role for 
caspase-8 as a negative upstream regulator of NLRP3 
inflammasome in dendritic cells and macrophages in a 
ripoptosome-dependent fashion [45-47]. Thus, in 
caspase-8 deficient cells, TLR activation triggers 
release of IL-1  even in absence of ATP as stimulating 
factor [47]. In this process, RIPK is supposed to play a 
determinant role [47]. Consequently, in these cells the 
role of caspase-8 can be seen as anti-inflammatory. 
However, a direct role for caspase-8 in the production 
of biologically active IL-1  in response to TLR3 and 
TLR4 stimulation in bone-marrow derived macrophages 
has been documented [48], a view with fits well with 
our in vivo observations.  
 
To shed further light in this issue, and considering that 
we did not find differences in terms of density of Iba1-
labeled microglia between CreLysMCasp8fl/fl mice and 
Casp8fl/fl mice in response to intranigral LPS, we 
decided to use a specific marker of M1 proinflammatory 
microglia, CD16/32 [3, 30, 32]. We confirmed that 
upon activation, microglia up-regulate expression of 
CD16/32 and more importantly, we found that density 
of CD16/32-immunolabeled cells was significantly 
lower in LPS-injected CreLysMCasp8fl/fl mice than in 
LPS-injected Casp8fl/fl mice. Altogether, our results 
strongly suggest an anti-inflammatory role of caspase-8 
in microglia-mediated brain inflammation.  
 
As stated above, we detected a dysregulated LPS-
induced iNOS expression in CreLysMCasp8fl/fl mice. It 
has been reported that expression of iNOS during 
inflammation in the CNS plays a role in the 
neurodegeneration in PD [49, 50].  Besides, Le et al. 
[51] showed that even though microglial activation 
results in the release of several cytokines and reactive 
oxygen species, only NO and H2O2 appeared to mediate 
the microglia-induced dopaminergic cell injury. 
Consequently, we decided to analyze CreLysMCasp8fl/fl 
mice in the MPTP animal model of PD. Analysis were 
performed at 3 days postinjection when inflammatory 
response is maximal and when neurodegeneration of the 
nigro-striatal dopaminergic system is evident. 
Proinflammatory microglia was analyzed in terms of 
CD16/32 immunohistochemistry in both SN and 
striatum. The integrity of the nigrostriatal dopaminergic 
system was analyzed by stereological analysis of nigral 
TH-labeled dopaminergic neurons in the SN or 
quantification of the density of the striatal dopaminergic 
nerve terminals. We found a remarkable up-regulation 
of CD16/32-immunolabeled cells in striatum and in the 
SN of Casp8fl/fl mice, this effect being especially 
evident in the pars compacta, where dopaminergic 
neurons are located. Double CD16/32 and Iba1 
immunofluorescence demonstrated the microglia 
phenotype of most CD16/32-labeled cells. Strikingly, 
density of CD16/32-immunolabeled microglia was 
robustly attenuated in the nigro-striatal system of 
CreLysMCasp8fl/fl mice in response to MPTP. We 
conclude that proinflammatory microglia activation is 
hindered in CreLysMCasp8fl/fl mice. 
 
iNOS-deficient mice are more resistant to MPTP-
induced dopaminergic cell loss than their wild-type 
littermates [11]. In addition, minocycline, a tetracycline 
derivative that blocks microglial activation, prevented 
MPTP-induced upregulation of iNOS and dopaminergic 
cell loss in mice treated with the toxin [52, 53]. Our 
analysis of the dopaminergic system demonstrated a 
more preserved integrity of this system in MPTP-treated 
CreLysMCasp8fl/fl mice as compared with Casp8fl/fl mice. 
These observations confirm and extend our previous 
observations using intranigral injections of IETD-fmk, a 
selective caspase-8 inhibitor [20] and highlight the 
neurotoxic role of proinflammatory activated microglia 
in dopaminergic degeneration. 
 
In conclusion, we have demonstrated the gene 
involvement of caspase-8 in proinflammatory microglia 
activation in two well defined animal models of 
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inflammation and dopaminergic degeneration including 
intranigral LPS injection and acute MPTP treatment. 
Significant less neurotoxic microglia activation was 
seen in the nigro-striatal system of CreLysMCasp8fl/fl 
mice in response to both challenges. These results 
reinforce the view of caspase-8 as a key regulator of 
brain inflammation.  
 
MATERIALS AND METHODS 
 
Generation of myeloid specific Caspase-8 deficient 
mice. Caspase-8f/f C57BL/6 mice (with the CASP8 
allele floxed at exon 3) were generously provided  by 
Prof. Steven M. Hedrick (University of California, San 
Diego) [54] (Fig. 1a). C57BL/6 mice containing a Cre 
recombinase under the control of LysM  promoter and 
enhancer elements, which allow its expression in the 
myeloid cell linage, including microglia, were obtained 
from Jackson Laboratories (strain name B6.129P2-
Lyz2tm1(cre)Ifo/J). A cross was set up between both strains 
and the offspring were Casp8f/+.CreLysM+/-. These 
offspring were crossed with Casp8f/f to generate 
Casp8f/f.CreLysM+/- (myeloidCasp8KO mice) and 
Casp8f/f. CreLysM-/- (WT mice). In order to make the 
breeding process more efficient we crossed Casp8f/f. 
CreLysM+/- with Casp8f/f mice to generate a 50 % 
Casp8f/f.CreLysM+/- and 50 % Casp8f/f.CreLysM-/-. 
Homozygous floxed CASP8 mice were born at the 
predicted Mendelian ratio and were indistinguishable 
from littermates. Wild type, single, and double floxed 
targeted CASP8 alleles were genotyped by PCR. 
 
Genotyping the mice. Genotyping of the mice was done 
by PCR analyses of tail DNA. For the PCR analyses, we 
used the oligonucleotides 5´-
ATAATTCCCCCAAATCCTCGCATC-3´ (A, sense) 
and 5´-GGCTCACTCCCAGGGCTTCCT-3´ (B, 
antisense) for the floxed and wild type alleles (Sigma-
Aldrich, St Louis, MO, USA); and 5´- 
CTTGGGCTGCCAGAATTTCTC-3´ (LysM Cre 
Common), 5´- TTACAGTCGGCCAGGCTGAC-3´ 
(LysM Cre Wild Type) and 5´- 
CCCAGAAATGCCAGATTACG-3´ (LysM Cre mutant)  
for the Cre transgenes (Jackson Labs Technologies, Inc. 
Las Vegas, NV. 89134). 
 
PCR and real-time PCR for assessing deletion 
efficiency in resting and activated microglia. The 
effectiveness of Cre-mediated deletion of the floxed 
caspase-8 allele was first roughly estimated by PCR in 
microglia isolated from the ventral mesencephalon 
from unlesioned (resting microglia) and from 
intranigrally LPS-injected animals (activated 
microglia) (see below).  
Microglial cells were isolated from dissected ventral 
mesencephalon after perfusion with ice-cold PBS, 
weighed, and enzymatically digested using Neural 
Tissue Dissociation Kit (Miltenyi Biotec S.L. Bergisch 
Gladbach, Germany), in combination with the 
gentleMACS Dissociator (Miltenyi Biotec S.L. 
Bergisch Gladbach, Germany), for 35 min at 37°C. 
Tissue debris was removed by passing the cell 
suspension through a 40 m cell strainer. Further 
processing was performed at 4°C. After enzymatic 
dissociation, cells were resuspended in 30% Percoll 
(Sigma-Aldrich, St Louis, MO, USA) and centrifuged for 
10 minutes at 700 g. The supernatant containing the 
myelin was removed, and the pelleted cells were washed 
with HBSS, followed by immunomagnetic isolation 
using CD11b (Microglial) MicroBeads mouse/human 
(Miltenyi Biotec S.L. Bergisch Gladbach, Germany). 
After myelin removal, cells were stained with CD11b 
(Microglial) MicroBeads in autoMACSRunning 
Buffer MACS separation Buffer (Miltenyi Biotec S.L. 
Bergisch Gladbach, Germany) for 15 minutes at 4°C. 
CD11b+ cells were separated in a magnetic field using 
LS columns (Miltenyi Biotec S.L. Bergisch Gladbach, 
Germany). The CD11b+ fraction was collected and used 
for further analyses.  
 
The isolated microglia was evaluated by FACS analysis. 
CD11b+ cells obtained from the isolation procedure 
were resuspended in PBS and immunostained with anti-
CD45 and anti-CD11b antibodies (Miltenyi Biotec S.L. 
Bergisch Gladbach, Germany) for 10 minutes at room 
temperature. CD11b and CD45 antibodies were 
fluorochrome-conjugated with PacificBlue and FITC 
respectively, and used at final dilutions of 1:10 (Figure 
1).  
 
For evaluation of caspase-8 gene deletion efficiency, we 
followed an ABC primer strategy (see figure 1 for 
locations of primers). DNA was extracted from the 
microglial fraction and subjected to PCR analysis using 
three primers (A, B and C): 5´-
ATAATTCCCCCAAATCCTCGCATC-3´ (A, sense 
for the wild-type, floxed, and deleted allele), 5´-
GGCTCACTCCCAGGGCTTCCT-3´ (B, antisense for 
the wild-type, and floxed allele) and 5´-
GCTACAGTGATGGTTTGTACATGG-3´ (C, 
antisense for the deleted allele) (Sigma-Aldrich, St 
Louis, MO, USA). 
 
For more precise quantitative evaluation, the extent of 
deletion in resident and activated microglia were assessed 
by real-time PCR. DNA levels from each sample were 
normalized using microglia from mice in which one of 
the caspase-8 alleles was knocked out (50% deletion). 
Primers A and B were used to quantify the floxed 
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undeleted caspase-8 gene whereas primers A and C 
were used to quantify the deleted caspase-8 gene. All 
samples were tested in triplicate. Ct were determined by 
plotting normalized fluorescent signal against cycle 
number, and the caspase-8 floxed and caspase-8 deleted 
copy number was calculated from the corresponding Ct 
values.  
 
LPS intranigral injection. Animals had free access to 
food and water.  Experiments were performed in 
accordance with the Guidelines of the European Union 
Council (86/609/EU), following Spanish regulations for 
the use of laboratory animals and approved by the 
Scientific Committee of the University of Seville. 
Experiments were performed in 2-4-month old age male 
animals. Mice were anaesthetized with chloral hydrate 
(400 mg/Kg) and positioned in a stereotaxic apparatus 
(Kopf Instruments, Tujunga, CA, USA) with a mouse 
adaptor. Intranigral LPS injections (from Escherichia 
coli, serotype 026:B6; Sigma) (2µg in 1µl or 4 µg in 2 
µl sterile saline) were made 1.2 mm posterior, 1.2 mm 
lateral and 5.0mm ventral to the lambda. For QPCR 
analysis, the SN was dissected from each mouse 6 h 
after the injection of saline or LPS, snap frozen in liquid 
nitrogen and stored at 80 ºC. For immuno-
histochemistry analysis, 24h later, mice were 
transcardially perfused under isoflurane anesthesia with 
4% paraformaldehyde, pH 7.4. Brains were removed, 
cryoprotected in sucrose and frozen in isopentane at -
80°C and serial coronal sections (25µm sections) 
covering the whole substantia nigra were cut with a 
cryostat  and mounted on gelatin-coated slides and 
further processed for immunohistochemistry. 
 
MPTP injections. Animals were treated with four 
injections of MPTP (16mg/kg) at 2h intervals. Four 
days after the last injection, animals were sacrificed and 
brains processed for immunohistochemistry as already 
stated. 
 
Immunohistological evaluation: Tyrosine hydroxylase, 
Iba-1, CD16/32 and cleaved caspase-8. Thaw-mounted 
25- m coronal sections were cut on a cryostat at 15 ºC 
and mounted in gelatin-coated slides. Primary 
antibodies used were rabbit-derived anti-tyrosine 
hydroxylase (anti-TH, Sigma, 1:300), rabbit-derived 
anti-Iba-1 (Wako, 1:500), rat-derived anti-CD16/32 
(BD, 1: 500) and rabbit-derived cleaved caspase-8 (Cell 
Signalling Technology, 1:150). Incubations and washes 
for all the antibodies were in Tris-buffered saline 
(TBS), pH 7.4. All work was done at room temperature. 
Sections were first microwaved pre-treated in 10mM 
citrate buffer pH 6.0 for 10min at 800W for antigen 
retrieval. Sections were washed and then treated with 
0.3% hydrogen peroxide in methanol for 20 min, 
washed again, and incubated in a solution containing 
TBS and 1% goat serum (Vector) for 60 min in a humid 
chamber. Slides were drained and further incubated 
with the primary antibody in TBS containing 1% serum 
and 0.25% Triton-X-100 for 24 h. Sections were then 
incubated for 2 h with either biotinylated goat anti-
rabbit IgG (Vector, 1:200) for TH, Iba-1  and cleaved 
caspase-8 or immunostaining or goat anti-rat IgG for 
CD16/32. The secondary antibody was diluted in TBS 
containing 0.25% Triton-X-100, and its addition was 
preceded by three 10-min rinses in TBS. Sections were 
then incubated with ExtrAvidin®-Peroxidase solution 
(Sigma, 1:100). The peroxidase was visualized with a 
standard diaminobenzidine/hydrogen peroxide reaction 
for 5 min. 
 
Immunofluorescence. Double-labelling were performed 
for Iba-1 and cleaved caspase-8, Iba1 and CD16/32 and 
CD16/32 and cleaved caspase-8. Two different Iba1 
antibodies were used: mouse anti-Iba-1 (Millipore) to 
co-localize with cleaved caspase-8 and rabbit anti-Iba-1 
(Wako) to co-localize with CD16/32. Sections were 
blocked with PBS containing 1% appropriate serums 
(Vector Laboratories) for 1 hour. The slides were 
washed three times in PBS, then incubated overnight at 
4°C with the two primary antibodies to be tested diluted 
in PBS containing 1% appropriate serums and 0.25% 
Triton X-100. Sections were incubated with the 
following secondary antibodies: a) mouse anti-Iba1: 
horse anti-mouse conjugated to Texas Red (1:200; 
Vector Laboratories), b) rabbit anti-Iba1 and rabbit anti-
cleaved caspase-8: horse anti-rabbit conjugated to 
Fluorescein (1:200; Vector Laboratories), c) rat anti-
CD16/32: chicken anti-rat conjugated to AlexaFluor 
594 (1:200, Invitrogen). Incubation with secondary 
antibodies were for 2 hours at room temperature in the 
dark. Their addition was preceded by three 10-minute 
rinses in PBS. Nuclei were counterstained with Hoechst 
dye (1 g/ml; Molecular Probes/Invitrogen). 
Fluorescence images were acquired using a Zeiss LSM 
7 DUO confocal laser scanning microscope (Carl Zeiss 
Microscopy, Jena, Germany) and processed using the 
associated software package (ZEN 2010; Carl Zeiss 
Microscopy). 
 
Immunohistochemistry data analysis. For counting the 
cell density of Iba1 and CD16/32 in the ventral 
mesencephalon in response to intranigral LPS injection, 
a systematic sampling of the area occupied by the 
immunolabelled positive cells in each section was made 
from a random starting point with a grid adjusted to 
count five fields per section. Analysis were made in a 
bounded region of the SN with a length of 300 microns 
in the anterior-posterior axis centred at the point of 
injection. In each case, five sections per animal were 
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used, with random starting point and systematically 
distributed through the anterior-posterior axis of the 
analyzed region. An unbiased counting frame of known 
area (40 x 25 µm = 1000 µm2) was superimposed on 
the tissue section image under a 100X oil immersion 
objective. The different types of Iba1-positive cells 
(displaying different shapes depending on their 
activation state) were counted as a whole and expressed 
as cells per mm2. In MPTP-treated animals, 
stereological analysis was performed to calculate both 
the number of TH-labelled dopaminergic neurons in SN 
and the number of Iba1- and CD16/32-labelled 
microglia in substantia nigra and striatum. Stereological 
analysis were estimated using a fractionator sampling 
design [55]. Counts were made at regular predetermined 
intervals (x = 150 m and y = 200 m) within each 
section. An unbiased counting frame of known area (40 
× 25 m = 1000 m2) was superimposed on the tissue 
section image under a 100× oil immersion objective. 
Therefore, the area sampling fraction is 1000/(150 × 
200) = 0.033. The entire z-dimension of each section 
was sampled; hence, the section thickness sampling 
fraction was 1. In all animals, 25- m sections, each 125 
m apart, were analysed; thus,  the  fraction  of  sections  
sampled was 25/125 = 0.20. The number of cells in the 
analyzed region was estimated by multiplying the 
number of neurons counted within the sample regions 
by the reciprocals of the area sampling fraction and the 
fraction of section sampled. TH immunohistochemistry 
in the striatum of mice intoxicated with MPTP was 
quantified using a computer-assisted software (analySIS). 
To carry out the quantification, five striatal sections from 
each condition, and processed under identical 
experimental conditions, were scanned at high resolution. 
The striatal region was delineated and its optical density 
measured based upon a calibrated grey scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Real time RT-PCR. The SN was dissected from each 
mouse 6 h after the injection of vehicle or LPS, snap 
frozen in liquid nitrogen and stored at 80 ºC. Total RNA 
was extracted from the SN using RNeasy® kit (Qiagen). 
cDNA was synthesized from 1 g of total RNA using 
QuantiTect® reverse transcription kit (Qiagen) in 20 l 
reaction volume as described by the manufacturer. Real-
time PCR was performed with iQSYBR® Green 
Supermix (Bio-Rad), 0.4 M primers and 1 l cDNA. 
Controls were carried out without cDNA. Amplification 
was run in a Mastercycler® ep realplex (Eppendorf) 
thermal cycler at 94 ºC for 3 min followed by 35 cycles 
of 94ºC for 30 s, 55ºC for 45 s, and 72ºC for 45 s, 
followed by a final elongation step at 72ºC  for 7 min. 
Following amplification, a melting curve analysis was 
performed by heating the reactions from 65 to 95ºC in 
1ºC intervals while monitoring fluorescence. Analysis 
confirmed a single PCR product at the predicted melting 
temperature. -actin served as reference gene and was 
used for samples normalization. Primer sequences for 
iNOS, tumour necrosis factor (TNF)- , interleukin (IL)-
6, IL-1  and -actin are shown in Table 1. The cycle at 
which each sample crossed a fluorescence threshold (Ct) 
was determined, and the triplicate values for each  
cDNA were averaged. Analyses of real-time PCR were 
done using a comparative Ct method integrated in a Bio-
Rad System Software.  
 
Statistical analysis. A minimum of five animals per 
experimental condition was analyzed. Results are 
expressed as mean ± SD. Most analysis were evaluated 
byANOVA followed by the LSD test for post hoc 
multiple range comparisons. Striatal TH density was 
evaluated by a  t-test using sidak-bonferroni test. Alphas 
value was set at 0.05. The Statgraphic Plus 3.0 software 
was used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Primers for RT PCR
 
Gene Forward primer Reverse primer 
Caspase-8 5- GGAAGATGACTTGAGCCTGC-
3 
5- GCTCTTGTTGACCTGGTCAC-3 
Lysozyme 
2 
5- GACCAAAGCACTGACTATGG-
3 
5- GATCCCACAGGCATTCACAG-3 
NOS2 5 -GTGGTGACAAGCACATTTGG-3  5 -AAGGCCA AACACAGCATACC-3  
TNF 5 -
CTGAGGTCAATCTGCCCAAGTAC-
3  
5 -
CTTCACAGAGCAATGACTCCAAAG-
3  
IL1B 5 -GCTGCTTCCAAACCTTTGAC-3  5 -TTCTCCACAGC CACAATGAG-3  
IL6 5 -GACCAAGACCATCCAATTC-3  5 -GGCATAACGCACTAGGTTTG-3  
ACTB 5 -TTGCTGACAGGATGCAGAAG-3  5 -TGATCCACATCTGCTGGAAG-3  
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